Quantum量子訊息有限公司
← 最新全球產業報告

U.S. Sucralfate Market

研究執行與發布:Coherent Market Insights · 發布日期 2026-02-02 · 152 頁
由量子訊息有限公司(Quantum Information)在台灣代理銷售與提供授權諮詢。

2026 年市場規模
USD 100 Mn
2033 年預估規模
USD 125 Mn
年複合成長率 CAGR
3.2%

以上數字由 Coherent Market Insights 於本報告中提出,量子訊息原樣引用。

出版商 Coherent Market Insights產業別 Healthcare & Life Sciences出版日期 2026-02-02頁數 152報告編號 CMI2975

授權報價

Single User Price$4,500 USD
Enterprise License$10,000 USD
洽詢購買 申請 Sample
完整報告名稱與涵蓋範圍
U.S. Sucralfate Market, By Formulation (Tablet and Liquid Suspension), By Indication (Gastric Ulcers, Duodenal Ulcers, Gastro Esophageal Reflux Disease (GERD), and Others Indications), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), By State (Illinois, Texas, New York, California, and Others)

報告摘要

Sucralfate is a hydroxy aluminum salt of sucrose octasulfate that functions as a local mucosal adherent. It forms a coating over ulcers by sticking to the affected area, which protects the area from acid and enzymes and helps ulcers to heal more quickly. Sucralfate can also be used in treating ulcers and upper gastrointestinal disorders of dog, horse, and cat, which may arise due to drugs (particularly non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids), toxic chemical ingestion, liver disease, renal failure, carcinoma, stress (trauma, shock, sepsis, and burns), and inflammatory bowel disease. Market Dynamics Increasing clinical trials for exploring different uses of sucralfate for different indications is a major factor driving U.S. sucralfate market growth. For instance, according to the study published by the National Center of Biotechnology Information, in 2016, a clinical trial conducted on Radiation Proctitis patients receiving sucralfate treatment showed 92.3% positive results in 16 weeks. Furthermore, monitoring of drugs including sucralfate in the U.S. by the government authorities for avoiding fatal conditions in the population is expected to drive the market growth. For instance, in 2017, the U.S. FDA updated name of 'Carafate suspension' to 'Carafate oral suspension' to avoid fatal complications with mistakenly intravenous administration of the drug. Key features of the study • This report provides in-depth analysis of the U.S. sucralfate market and provides market size (USD million) and compound annual growth rate (CAGR %) for the forecast period (2018–2026), considering 2017 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players • It profiles key players in the U.S. sucralfate market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans • Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Allergan plc, Vertice Pharma LLC, and Pharmaceutical Associates Inc. • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics. • The U.S. sucralfate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the U.S. sucralfate market Market Segmentation • Formulation Insights (Revenue, USD Mn, 2026 - 2033) o Tablet o Liquid Suspension • Indication Insights (Revenue, USD Mn, 2026 - 2033) o Gastric Ulcers o Duodenal Ulcers o Gastro Esophageal Reflux Disease (GERD) o Others • Distribution Channel Insights (Revenue, USD Mn, 2026 - 2033) o Hospital Pharmacy o Retail Pharmacy o Online Pharmacy • State Insights (Revenue, USD Mn, 2026 - 2033) o Illinois o Texas o New York o California o Others • Key Players Insights o Teva Pharmaceutical Industries Ltd. o Allergan plc o Vertice Pharma LLC o Pharmaceutical Associates Inc. (PAI)
目錄 Table of Contents
Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Overview o Report Description  Market Definition and Scope o Executive Summary  U.S. Sucralfate Market, By Formulation  U.S. Sucralfate Market, By Indication  U.S. Sucralfate Market, By Distribution Channel  U.S. Sucralfate Market, By State 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics o Impact Analysis o Key Highlights o Regulatory Scenario o Product Launches/Approvals o PEST Analysis o PORTER’s Analysis o Market Opportunities o Regulatory Scenario o Key Developments o Industry Trend 4. U.S. Sucralfate Market, By Formulation, 2026-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Tablet  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) o Liquid Suspension  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) 5. U.S. Sucralfate Market, By Indication, 2026-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Gastric Ulcers  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) o Duodenal Ulcers  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) o Gastro Esophageal Reflux Disease (GERD)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) 6. U.S. Sucralfate Market, By Distribution Channel, 2026-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Hospital Pharmacy  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) o Retail Pharmacy  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) o Online Pharmacy  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn) 7. U.S. Sucralfate Market, By State, 2026 - 2033, Value (USD Mn) o Introduction  Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Mn)  Market Y-o-Y Growth Analysis (%), 2021 - 2033, Value (USD Mn)  Regional Trends o Illinois  Market Size and Forecast, By Formulation, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By Indication, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By Distribution Channel, 2026 - 2033, Value (USD Mn) o Texas  Market Size and Forecast, By Formulation, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By Indication, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By Distribution Channel, 2026 - 2033, Value (USD Mn) o New York  Market Size and Forecast, By Formulation, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By Indication, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By Distribution Channel, 2026 - 2033, Value (USD Mn) o California  Market Size and Forecast, By Formulation, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By Indication, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By Distribution Channel, 2026 - 2033, Value (USD Mn) o Others  Introduction  Market Size and Forecast, By Formulation, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By Indication, 2026 - 2033, Value (USD Mn)  Market Size and Forecast, By Distribution Channel, 2026 - 2033, Value (USD Mn) 8. Competitive Landscape o Teva Pharmaceutical Industries Ltd.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Allergan plc  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Vertice Pharma LLC  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Pharmaceutical Associates Inc. (PAI)  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies 9. Analyst Recommendations o Wheel of Fortune o Analyst View o Coherent Opportunity Map 10. References and Research Methodology o References o Research Methodology o About us

提及公司

Teva Pharmaceutical Industries Ltd.Allergan plcVertice Pharma LLCPharmaceutical Associates Inc. (PAI)

同分類最新報告(醫療與生命科學)

常見問題

這份報告可以先索取樣本嗎?

可以。建議購買前先申請樣本,提出申請後約 2 個工作天內提供,您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算?

報告以美元標價,台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本(單人/多人/企業全站)價格不同,量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付?如何付款?

一般 3–7 個工作天交付,實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票,30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們